CLINICAL TRIALS PROFILE FOR MAFENIDE ACETATE
✉ Email this page to a colleague
All Clinical Trials for MAFENIDE ACETATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00586729 ↗ | Vashe Wound Therapy Study | Completed | PuriCore, Inc. | N/A | 2009-07-01 | This study will evaluate the efficacy, safety, and tolerability of topical Vashe™ Wound Therapy applied to gauze dressing every 6 hours or as necessary to keep dressing moist versus 5% Mafenide Acetate applied to gauze dressing every 6 hours or as necessary to keep dressing moist for a total treatment duration of 5 days. |
| NCT00586729 ↗ | Vashe Wound Therapy Study | Completed | Maricopa Integrated Health System | N/A | 2009-07-01 | This study will evaluate the efficacy, safety, and tolerability of topical Vashe™ Wound Therapy applied to gauze dressing every 6 hours or as necessary to keep dressing moist versus 5% Mafenide Acetate applied to gauze dressing every 6 hours or as necessary to keep dressing moist for a total treatment duration of 5 days. |
| NCT00586729 ↗ | Vashe Wound Therapy Study | Completed | Valleywise Health | N/A | 2009-07-01 | This study will evaluate the efficacy, safety, and tolerability of topical Vashe™ Wound Therapy applied to gauze dressing every 6 hours or as necessary to keep dressing moist versus 5% Mafenide Acetate applied to gauze dressing every 6 hours or as necessary to keep dressing moist for a total treatment duration of 5 days. |
| NCT00634166 ↗ | Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group | Terminated | Mylan Pharmaceuticals | Phase 4 | 2007-09-01 | The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial. |
| NCT00634166 ↗ | Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group | Terminated | Mylan Bertek Pharmaceuticals | Phase 4 | 2007-09-01 | The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MAFENIDE ACETATE
Condition Name
Clinical Trial Locations for MAFENIDE ACETATE
Trials by Country
Clinical Trial Progress for MAFENIDE ACETATE
Clinical Trial Phase
Clinical Trial Sponsors for MAFENIDE ACETATE
Sponsor Name
